Home/Filings/4/0001640455-21-000029
4//SEC Filing

MURRAY RICHARD /CA/ 4

Accession 0001640455-21-000029

CIK 0001640455other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 5:48 PM ET

Size

9.9 KB

Accession

0001640455-21-000029

Insider Transaction Report

Form 4
Period: 2021-02-01
MURRAY RICHARD /CA/
DirectorCEO and President
Transactions
  • Award

    Common Stock

    2021-02-01+75,000215,371 total
  • Award

    Common Stock

    2021-02-03+7,500222,871 total
  • Award

    Stock Option (Right to Buy)

    2021-02-01+150,000150,000 total
    Exercise: $11.89Exp: 2031-02-01Common Stock (150,000 underlying)
  • Award

    Stock Option (Right to Buy)

    2021-02-01+15,00015,000 total
    Exercise: $12.67Exp: 2031-02-03Common Stock (15,000 underlying)
Footnotes (1)
  • [F1]The option will vest quarterly in 16 equal installments following January 1, 2021.

Issuer

Jounce Therapeutics, Inc.

CIK 0001640455

Entity typeother

Related Parties

1
  • filerCIK 0001242935

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 5:48 PM ET
Size
9.9 KB